10,061 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Purchased by ZEGA Investments LLC

ZEGA Investments LLC acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 10,061 shares of the healthcare conglomerate's stock, valued at approximately $5,358,000. UnitedHealth Group comprises about 1.3% of ZEGA Investments LLC's portfolio, making the stock its 13th biggest position.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. NewSquare Capital LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at about $25,000. AlphaMark Advisors LLC bought a new position in UnitedHealth Group during the 4th quarter worth approximately $30,000. Promus Capital LLC bought a new stake in UnitedHealth Group in the fourth quarter valued at approximately $32,000. RPg Family Wealth Advisory LLC bought a new position in shares of UnitedHealth Group during the third quarter worth $37,000. Finally, Pillar Financial Advisors LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at $40,000. Institutional investors own 87.86% of the company's stock.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction dated Friday, January 17th. The shares were bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company's stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 0.33% of the company's stock.

Remove Ads

UnitedHealth Group Stock Performance

NYSE:UNH traded up $4.67 on Wednesday, hitting $518.10. The company's stock had a trading volume of 3,253,715 shares, compared to its average volume of 4,082,722. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The stock has a fifty day moving average of $509.10 and a two-hundred day moving average of $545.56. The firm has a market capitalization of $473.92 billion, a P/E ratio of 33.43, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company's quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the previous year, the company earned $5.83 earnings per share. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.62%. UnitedHealth Group's payout ratio is currently 54.19%.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the company. HSBC upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price target for the company in a report on Friday, January 10th. Cantor Fitzgerald reiterated an "overweight" rating and issued a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Piper Sandler cut their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a research report on Thursday, January 2nd. Hsbc Global Res upgraded UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a report on Friday, January 10th. Finally, Oppenheimer lifted their target price on UnitedHealth Group from $610.00 to $640.00 and gave the company an "outperform" rating in a research report on Friday, December 6th. Twenty analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group has an average rating of "Buy" and an average target price of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.